Literature DB >> 549210

Altered drug metabolism in hepatosplenic schistosomiasis.

P C Brant, A Prata.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 549210

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


× No keyword cloud information.
  5 in total

1.  Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.

Authors:  Gina S El-Feky; Wael S Mohamed; Hanaa E Nasr; Naglaa M El-Lakkany; Sayed H Seif El-Din; Sanaa S Botros
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

3.  Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice.

Authors:  Naglaa El-Lakkany; Sayed Hassan Seif El-Din; Lamia Heikal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-03-30       Impact factor: 2.441

4.  Propranolol disposition in patients with hepatosplenic schistosomiasis.

Authors:  M M Homeida; H M Ali; B M Arbab; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

5.  The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.

Authors:  I el-Raghy; D J Back; F Osman; M A Nafeh; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.